Events2Join

A Multicenter Evaluation of Different Chemotherapy Regimens in ...


A Multicenter Evaluation of Different Chemotherapy Regimens in ...

Single-agent cisplatin can be considered in the standard chemotherapy regimen for older patients with HNSCC who can tolerate cisplatin.

A Multicenter Evaluation of Different Chemotherapy Regimens in ...

A multicenter evaluation of different chemotherapy regimens in older adults with head and neck squamous cell carcinoma undergoing definitive chemoradiation.

A Multicenter Evaluation of Different Chemotherapy Regimens in ...

Conclusions. Single-agent cisplatin can be considered in the standard chemotherapy regimen for older patients with HNSCC who can tolerate cisplatin. Cumulative ...

A Multicenter Evaluation of Different Chemotherapy Regimens in ...

A Multicenter Evaluation of Different. Chemotherapy Regimens in Older Adults With. Head and Neck Squamous Cell Carcinoma. Undergoing Definitive Chemoradiation.

A Multicenter Evaluation of Different Chemotherapy Regimens in ...

A Multicenter Evaluation of Different Chemotherapy Regimens in Older Adults With Head and Neck Squamous Cell Carcinoma Undergoing Definitive Chemoradiation.

A Multicenter Evaluation of Different Chemotherapy Regimens in ...

A Multicenter Evaluation of Different Chemotherapy Regimens in Older Adults With. Head and Neck Squamous Cell Carcinoma Undergoing Definitive Chemoradiation.

A Multicenter Evaluation of Different Chemotherapy Regimens in ...

PDF | On Oct 1, 2023, Alexander Rühle and others published A Multicenter Evaluation of Different Chemotherapy Regimens in Older Adults With ...

A Multicenter Evaluation of Different Chemotherapy Regimens in ...

Learn more about A Multicenter Evaluation of Different Chemotherapy Regimens in Older Adults With Head and Neck Squamous Cell Carcinoma Undergoing ...

A Multicenter Evaluation of Different Chemotherapy Regimens in ...

A Multicenter Evaluation of Different Chemotherapy Regimens in Older Adults With Head and Neck Squamous Cell Carcinoma Undergoing Definitive Chemoradiation.

A Multicenter Evaluation of Different Chemotherapy Regimens in ...

Article "A Multicenter Evaluation of Different Chemotherapy Regimens in Older Adults With Head and Neck Squamous Cell Carcinoma Undergoing Definitive ...

A Multicenter Evaluation of Different Chemotherapy Regimens in ...

The number of older adults with head-and-neck squamous cell carcinoma (HNSCC) is increasing, and treatment of these patients is challenging.

Domenico Romanello - X.com

A Multicenter Evaluation of Different Chemotherapy Regimens in Older Adults With Head and Neck Squamous Cell Carcinoma Undergoing Definitive ...

Evaluation of Concomitant Systemic Treatment in Older Adults With ...

Although the MACH-NC study did not support superiority of multiagent chemotherapy, and both US and European guidelines recommend the use of ...

Short‐Term Efficacy of Different First‐Line Chemotherapy Regimens ...

This study intends to compare short‐term efficacy of 12 chemotherapy regimens in treatment of advanced non‐small cell lung cancer (NSCLC) by a network ...

A multicenter evaluation of sequential multimodality therapy and ...

Sequential CRC was associated with improved survival in women with advanced stage disease compared to other sequencing modalities with a similar adverse effect ...

Comparison of Four Chemotherapy Regimens for Advanced Non ...

The response rate and survival did not differ significantly between patients assigned to receive cisplatin and paclitaxel and those assigned to receive any of ...

A multicenter evaluation of intensified, ambulatory ...

Histologic necrosis of metastases was >90% in 7 patients and complete in 1 patient. The median progression free survival and survival durations ...

Adapted EXTREME regimen in the first-line treatment of fit, older ...

The search returned 45 publications, most of which reported on platinum-based chemotherapy combinations. In fit patients with recurrent or ...

Phase II randomized multicenter study evaluating a treatment ...

The intention-to-treat objective response rate was 10.8% [95% confidence interval (CI) 0.8% to 20.8%] in group A compared with 25% (95% CI 10% to 40%) in group ...

Efficacy and Toxicity of Different Chemotherapy Protocols for ... - MDPI

(1) Background: The optimal chemotherapy (CHT) regimen for concurrent chemoradiation (cCRT) is not well defined. In this secondary analysis of the ...